Wealth Enhancement Advisory Services LLC Acquires 6,032 Shares of GRAIL, Inc. $GRAL

Wealth Enhancement Advisory Services LLC grew its holdings in GRAIL, Inc. (NASDAQ:GRAL) by 21.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,195 shares of the company’s stock after acquiring an additional 6,032 shares during the quarter. Wealth Enhancement Advisory Services LLC owned 0.10% of GRAIL worth $1,758,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Caldwell Sutter Capital Inc. bought a new position in GRAIL in the first quarter worth $28,000. KBC Group NV lifted its position in GRAIL by 187.7% in the first quarter. KBC Group NV now owns 1,430 shares of the company’s stock worth $37,000 after purchasing an additional 933 shares during the period. S.A. Mason LLC lifted its position in GRAIL by 50.1% in the first quarter. S.A. Mason LLC now owns 1,499 shares of the company’s stock worth $38,000 after purchasing an additional 500 shares during the period. NewEdge Advisors LLC lifted its position in GRAIL by 390.3% in the first quarter. NewEdge Advisors LLC now owns 1,760 shares of the company’s stock worth $45,000 after purchasing an additional 1,401 shares during the period. Finally, Signaturefd LLC lifted its position in GRAIL by 273.0% in the first quarter. Signaturefd LLC now owns 1,876 shares of the company’s stock worth $48,000 after purchasing an additional 1,373 shares during the period.

GRAIL Price Performance

Shares of GRAL stock opened at $58.77 on Tuesday. The stock has a market cap of $2.12 billion, a P/E ratio of -4.48 and a beta of 3.20. GRAIL, Inc. has a one year low of $12.33 and a one year high of $63.99. The stock has a fifty day moving average price of $36.82 and a 200 day moving average price of $36.28.

GRAIL (NASDAQ:GRAL) last issued its earnings results on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing the consensus estimate of ($3.14) by ($0.04). The firm had revenue of $35.54 million during the quarter, compared to the consensus estimate of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. Equities research analysts anticipate that GRAIL, Inc. will post -15.15 EPS for the current year.

Insider Buying and Selling at GRAIL

In other GRAIL news, President Joshua J. Ofman sold 4,202 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $32.02, for a total transaction of $134,548.04. Following the completion of the transaction, the president directly owned 487,874 shares in the company, valued at $15,621,725.48. This represents a 0.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Aaron Freidin sold 8,000 shares of the stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total value of $311,440.00. Following the transaction, the chief financial officer owned 286,020 shares of the company’s stock, valued at $11,134,758.60. This represents a 2.72% decrease in their ownership of the stock. The disclosure for this sale can be found here.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.